imatinib has been researched along with Experimental Mammary Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cao, DS | 1 |
| Jiang, SL | 1 |
| Guan, YD | 1 |
| Chen, XS | 1 |
| Zhang, LX | 1 |
| Zhang, Y | 1 |
| Chen, AF | 1 |
| Yang, JM | 1 |
| Cheng, Y | 1 |
1 other study available for imatinib and Experimental Mammary Neoplasms
| Article | Year |
|---|---|
A multi-scale systems pharmacology approach uncovers the anti-cancer molecular mechanism of Ixabepilone.
Topics: Animals; Antineoplastic Agents; Apoptosis; Cell Proliferation; Dose-Response Relationship, Drug; Dru | 2020 |